Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Nuvalent Inc.
Company

Nuvalent Inc.

Tracked across 2 events · 31 articles · First seen Jul 06, 2026 · Last active Jul 27, 2026

Sentiment
50
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 50
Regulatory
FDA approves GSK's Jideytro for NSCLC
Impact: Nuvalent Inc.'s drug candidate Jideytro, acquired by GSK, received FDA approval, validating its pipeline and acquisition value.
Jul 22, 2026 · 6 articles
4 50
Business
Scribe Therapeutics upsized IPO closes
Impact: Nuvalent Inc. was acquired by GSK plc, reflecting strong interest in innovative biotech assets.
Jul 06, 2026 · 25 articles
ERGEN INTELLIGENCE
Track Nuvalent Inc. live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.